Abstract
Extreme sporting events are exceeding popular and a growing number of persons worldwide of all fitness-health levels are participating in them on an annual basis. Currently 350 million people are affected with diabetes worldwide; approximately 10% of those have type 1 diabetes and rely on insulin for maintaining their health. Once thought unimaginable and dangerous, a growing number of these subjects are now engaging in extreme sports events. This chapter reviews the very special challenge on glucose metabolism and counterregulation posed by such activities in type 1 diabetes, and it presents the existing scientific evidence supporting the notion they are compatible with this condition. At the same time, the areas where such data are lacking are underscored. The even more unlikely situation of type 2 diabetics and extreme sports is also addressed, emphasizing the almost complete void of scientific evidence in this arena. Studies are urgently needed to fill in the information gap and to provide the scientific grounds for professional guidance to diabetic patients. Until then, it is suggested that sports organizations along with health-care professionals based their recommendations on the best available evidence (as well as the personal experience of the health-care provider and the diabetic patient).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Diabetes Association. Physical activity/exercise and diabetes. Position statement. Diabetes Care. 2004;27 Suppl 1:S58–62.
Vranic M, Gauthier C, Bilinski D, Wasserman D, El Tayeb K, Hetenyi Jr G, et al. Catecholamine responses and their interactions with other glucoregulatory hormones. Am J Physiol. 1984;247(2 Pt 1):E145–56.
Mazzeo RS. Catecholamine response to acute and chronic exercise. Med Sci Sports Exerc. 1991;23(7):839–45.
Goodyear LJ, Hirshman MF, Horton ES. Exercise-induced translocation of skeletal muscle glucose Âtransporters. Am J Physiol. 1991;261(6 Pt 1):E795–9.
Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol. 1997;273(6 Pt 1):E1039–51.
Drouin R, Lavoie C, Bourque J, Ducros F, Poisson D, Chiasson JL. Increased hepatic glucose production response to glucagon in trained subjects. Am J Physiol. 1998;274(1 Pt 1):E23–8.
Lavoie C, Ducros F, Bourque J, Langelier H, Chiasson JL. Glucose metabolism during exercise in man: the role of insulin and glucagon in the regulation of hepatic glucose production and gluconeogenesis. Can J Physiol Pharmacol. 1997;75(1):36–43.
Jensen MD. Fate of fatty acids at rest and during exercise: regulatory mechanisms. Acta Physiol Scand. 2003;178(4):385–90.
Jentjens R, Jeukendrup A. Determinants of post-exercise glycogen synthesis during short-term recovery. Sports Med. 2003;33(2):117–44.
Bolli G, Calabrese G, De Feo P, Compagnucci P, Zega G, Angeletti G, et al. Lack of glucagon response in glucose-counter-regulation in type I (insulin-dependent) diabetics: absence of recovery after prolonged Âoptimal insulin therapy. Diabetologia. 1982;22(2):100–5.
Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest. 1993;91(3):819–28.
Sandoval DA, Guy DL, Richardson MA, Ertl AC, Davis SN. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus. Am J Physiol Endocrinol Metab. 2006;290(6):E1331–8.
Chansky ME, Corbett JG, Cohen E. Hyperglycemic emergencies in athletes. Clin Sports Med. 2009;28(3): 469–78.
Joint Position Statement of the American College of Sports Medicine. The American Dietetic Association and Dietitians of Canada: nutrition and athletic performance. J Am Diet Assoc. 2000;32(12):2130–45.
Jimenez CC, Corcoran MH, Crawley JT, Guyton Hornsby W, Peer KS, Philbin RD, et al. National Athletic Trainers’ Association position statement: management of the athlete with type 1 diabetes mellitus. J Athl Train. 2007;42(4):536–45.
Hartvig Jensen T, Darre E, Holmich P, Jahnsen F. Insulin-dependent diabetes mellitus and marathon running. Br J Sports Med. 1987;21(1):51–2.
Meinders AE, Willekens FL, Heere LP. Metabolic and hormonal changes in IDDM during long-distance run. Diabetes Care. 1988;11(1):1–7.
Tuominen JA, Ebeling P, Koivisto VA. Exercise increases insulin clearance in healthy man and insulin-dependent diabetes mellitus patients. Clin Physiol. 1997;17(1):19–30.
Boehncke S, Poettgen K, Maser-Gluth C, Reusch J, Boehncke WH, Badenhoop K. Endurance capabilities of triathlon competitors with type 1 diabetes mellitus. Dtsch Med Wochenschr. 2009;134(14):677–82.
Murillo S, Brugnara L, Novials A. One year follow-up in a group of half-marathon runners with type-1 diabetes treated with insulin analogues. J Sports Med Phys Fitness. 2010;50(4):506–10.
Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, et al. Continuous glucose monitoring in diabetic long distance runners. Int J Sports Med. 2005;26(9):774–80.
Hillson RM. Diabetes outward bound mountain course, Eskdale, Cumbria. Diabet Med. 1984;1(1):59–63.
Moore K, Vizzard N, Coleman C, McMahon J, Hayes R, Thompson CJ. Extreme altitude mountaineering and type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro expedition. Diabet Med. 2001;18(9):749–55.
Pavan P, Sarto P, Merlo L, Casara D, Ponchia A, Biasin R, et al. Metabolic and cardiovascular parameters in type 1 diabetes at extreme altitude. Med Sci Sports Exerc. 2004;36(8):1283–9.
Kalson NS, Davies AJ, Stokes S, Frost H, Whitehead AG, Tyrrell-Marsh I, et al. Climbers with diabetes do well on Mount Kilimanjaro. Diabet Med. 2007;24(12):1496.
Braun B, Mawson JT, Muza SR, Dominick SB, Brooks GA, Horning MA, et al. Women at altitude: carbohydrate utilization during exercise at 4,300 m. J Appl Physiol. 2000;88:246–56.
Fink KS, Christensen DB, Ellsworth A. Effect of high altitude on blood glucose meter performance. Diabetes Technol Ther. 2002;4(5):627–35.
Oberg D, Ostenson CG. Performance of glucose dehydrogenase- and glucose oxidase-based blood glucose meters at high altitude and low temperature (Letter). Diabetes Care. 2005;28:1261.
Burbaker PL. Adventure travel and type 1 diabetes: the complicating effects of high altitude. Diabetes Care. 2005;28(10):2563–72.
Lynch JH, Bove AA. Diving medicine: a review of current evidence. J Am Board Fam Med. 2009;22(4): 399–407.
PADI—Professional Association of Diving Instructors. Worldwide Corporate Statistics 2010. http://www.padi.com/scuba/uploadedFiles/2010%20WW%20Statistics.pdf
Dear Gde L, Dovenbarger JA, Corson KS, Stolp BW, Moon RE. Diabetes among recreational divers. Abstract of the undersea and hyperbaric medical society. Annual Scientific Meeting, Denver, CO; 22–26 June 1994.
Edge CJ, St Leger Dowse M, Bryson P. Scuba diving with diabetes mellitus—the UK experience 1991–2001. Undersea Hyperb Med. 2005;32(1):27–37.
Edge CJ, Grieve AP, Gibbons N, O’Sullivan F, Bryson P. Control of blood glucose in a group of diabetic scuba divers. Undersea Hyperb Med. 1997;24(3):201–7.
Dear Gde L, Pollock NW, Uguccioni DM, Dovenbarger J, Feinglos MN, Moon RE. Plasma glucose responses in recreational divers with insulin-requiring diabetes. Undersea Hyperb Med. 2004;31(3):291–301.
Adolfsson P, Ornhagen H, Jendle J. Accuracy and reliability of continuous glucose monitoring in individuals with type 1 diabetes during recreational diving. Diabetes Technol Ther. 2009;11(8):493–7.
Bonomo M, Cairoli R, Verde G, Morelli L, Moreo A, Grottaglie MD, et al. Safety of recreational scuba diving in type 1 diabetic patients: the Deep Monitoring programme. Diabetes Metab. 2009;35(2):101–7.
Pollock NW, Uguccioni DM, Dear GdeL, editors. Diabetes and recreational diving: guidelines for the future. Proceedings of the UHMS/DAN 2005 June 19 Workshop. Durham, NC: DAN; 2005.
May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999–2008. Pediatrics. 2012;129:1035–41.
Galbo H, Tobin L, van Loon LJC. Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake. Appl Physiol Nutr Metab. 2007; 32:568–75.
Gillen JB, Little JP, Punthakee Z, Tarnopolsky MA, Riddell MC, Gibala MJ. Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes. Diabetes Obes Metab. 2012;14(6):575–7.
Van Dijk JW, Manders RJF, Tummers K, Bonomi AG, Stehouwer CDA, Hartgens F, et al. Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia. 2012;55:1273–82.
Diabetic brothers complete triathlon. http://www.ksl.com/?nid=1010&sid=16138518. Accessed 9 June 2012.
Marathon and type 2? http://www.diabeteswith.com/type-2/diabetic-1450.html. Accessed 9 June 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tordjman, K., Hackney, A.C., Constantini, N. (2013). Extreme Sports and Type 1 Diabetes Mellitus: An Oxymoron or a Growing Reality?. In: Constantini, N., Hackney, A. (eds) Endocrinology of Physical Activity and Sport. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-314-5_26
Download citation
DOI: https://doi.org/10.1007/978-1-62703-314-5_26
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-313-8
Online ISBN: 978-1-62703-314-5
eBook Packages: MedicineMedicine (R0)